Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
ObjectiveThe primary objective of this screening study is to test patient specimens to determine eligibility for participation in the biomarker-driven and non-matched sub-studies included within the Lung-MAP umbrella protocol.
Protocol #LUNGMAP
Trial Phase:Phase II/III
Principal Investigator:Martins, Renato
Cancer Type
- Lung
- Hunter Holmes McGuire VAMC
- Hunter Holmes McGuire VAMC RTOG Institution #
- Lynchburg Hematology Oncology Clinic
- Inc.
- Shenandoah Oncology
- Shenandoah Oncology
- PC
- Stony Point
- VCU Community Memorial Healthcenter
- Virginia Cancer Institute
- Virginia Commonwealth University
Get more detailed information at ClinicalTrials.gov
- Protocol Type Screening
-
Research Study Team
Carrie Donovan, RN
Phone: +1 804-628-3836
Email Study Contact
Click "I'm Interested" to get started. If you have questions, call our study contact.
I'm InterestedHave a question? We're here to help.
Email us or call us with your request.
Send an Email ยป (804) 628-6430